Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.
Identifieur interne : 000312 ( Main/Exploration ); précédent : 000311; suivant : 000313Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.
Auteurs : Jeffrey C. Kwong [Canada] ; Michael A. Campitelli ; Jonathan B. Gubbay ; Adriana Peci ; Anne-Luise Winter ; Romy Olsha ; Robert Turner ; Laura C. Rosella ; Natasha S. CrowcroftSource :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2013.
Descripteurs français
- KwdFr :
- Facteurs de l'âge, Femelle, Grippe humaine (), Grippe humaine (épidémiologie), Hospitalisation (), Humains, Modèles logistiques, Mâle, Ontario (épidémiologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Études de cohortes.
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Vaccins antigrippaux.
- épidémiologie : Grippe humaine, Ontario.
- Facteurs de l'âge, Femelle, Grippe humaine, Hospitalisation, Humains, Modèles logistiques, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes.
English descriptors
- KwdEn :
- Age Factors, Aged, Aged, 80 and over, Cohort Studies, Female, Hospitalization (statistics & numerical data), Humans, Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Logistic Models, Male, Ontario (epidemiology).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , immunology : Influenza Vaccines.
- geographic , epidemiology : Ontario.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Hospitalization.
- Age Factors, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Logistic Models, Male.
Abstract
BACKGROUND
Although annual influenza immunization is recommended for adults aged ≥65 years due to the substantial burden of illness, the evidence base for this recommendation is weak. Prior observational studies that examined influenza vaccine effectiveness against nonspecific serious outcomes suffered from selection bias and the lack of laboratory confirmation for influenza infection. The objective of this study was to determine the effectiveness of the 2010-2011 seasonal influenza vaccine against laboratory-confirmed influenza hospitalizations among community-dwelling elderly adults, a serious and highly specific outcome.
METHODS
We conducted a test-negative study of community-dwelling adults aged >65 years in Ontario, Canada. Respiratory specimens collected between 1 December 2010 and 30 April 2011 from patients admitted to acute care hospitals were tested for influenza using nucleic acid amplification techniques. Influenza vaccination was ascertained from physician billing claims through linkage to health administrative datasets.
RESULTS
Receipt of the 2010-2011 seasonal influenza vaccine was associated with a 42% (95% confidence interval, 29%-53%) reduction in laboratory-confirmed influenza hospitalizations. Vaccine effectiveness estimates were consistent across age groups, by sex, and regardless of outcome severity, timing of testing, and when considering individuals vaccinated <7 or <14 days prior to admission as unvaccinated.
CONCLUSIONS
Results of this study will better inform decision making regarding influenza vaccination of elderly adults. Similar analyses are needed annually due to antigenic drift and frequent changes in influenza vaccine composition. The linkage of routinely collected laboratory testing and health administrative data represents an efficient method for estimating influenza vaccine effectiveness that complements prospective studies.
DOI: 10.1093/cid/cit404
PubMed: 23788243
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.</title><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author><author><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name></author><author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name></author><author><name sortKey="Olsha, Romy" sort="Olsha, Romy" uniqKey="Olsha R" first="Romy" last="Olsha">Romy Olsha</name></author><author><name sortKey="Turner, Robert" sort="Turner, Robert" uniqKey="Turner R" first="Robert" last="Turner">Robert Turner</name></author><author><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name></author><author><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23788243</idno><idno type="pmid">23788243</idno><idno type="doi">10.1093/cid/cit404</idno><idno type="wicri:Area/Main/Corpus">000347</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000347</idno><idno type="wicri:Area/Main/Curation">000347</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000347</idno><idno type="wicri:Area/Main/Exploration">000347</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.</title><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author><author><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name></author><author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name></author><author><name sortKey="Olsha, Romy" sort="Olsha, Romy" uniqKey="Olsha R" first="Romy" last="Olsha">Romy Olsha</name></author><author><name sortKey="Turner, Robert" sort="Turner, Robert" uniqKey="Turner R" first="Robert" last="Turner">Robert Turner</name></author><author><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name></author><author><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Hospitalization (statistics & numerical data)</term><term>Humans</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Logistic Models</term><term>Male</term><term>Ontario (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Facteurs de l'âge</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Hospitalisation ()</term><term>Humains</term><term>Modèles logistiques</term><term>Mâle</term><term>Ontario (épidémiologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term><term>Études de cohortes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Ontario</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Logistic Models</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de l'âge</term><term>Femelle</term><term>Grippe humaine</term><term>Hospitalisation</term><term>Humains</term><term>Modèles logistiques</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p> Although annual influenza immunization is recommended for adults aged ≥65 years due to the substantial burden of illness, the evidence base for this recommendation is weak. Prior observational studies that examined influenza vaccine effectiveness against nonspecific serious outcomes suffered from selection bias and the lack of laboratory confirmation for influenza infection. The objective of this study was to determine the effectiveness of the 2010-2011 seasonal influenza vaccine against laboratory-confirmed influenza hospitalizations among community-dwelling elderly adults, a serious and highly specific outcome.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p> We conducted a test-negative study of community-dwelling adults aged >65 years in Ontario, Canada. Respiratory specimens collected between 1 December 2010 and 30 April 2011 from patients admitted to acute care hospitals were tested for influenza using nucleic acid amplification techniques. Influenza vaccination was ascertained from physician billing claims through linkage to health administrative datasets.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p> Receipt of the 2010-2011 seasonal influenza vaccine was associated with a 42% (95% confidence interval, 29%-53%) reduction in laboratory-confirmed influenza hospitalizations. Vaccine effectiveness estimates were consistent across age groups, by sex, and regardless of outcome severity, timing of testing, and when considering individuals vaccinated <7 or <14 days prior to admission as unvaccinated.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p> Results of this study will better inform decision making regarding influenza vaccination of elderly adults. Similar analyses are needed annually due to antigenic drift and frequent changes in influenza vaccine composition. The linkage of routinely collected laboratory testing and health administrative data represents an efficient method for estimating influenza vaccine effectiveness that complements prospective studies.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23788243</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.</ArticleTitle><Pagination><MedlinePgn>820-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/cit404</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND"> Although annual influenza immunization is recommended for adults aged ≥65 years due to the substantial burden of illness, the evidence base for this recommendation is weak. Prior observational studies that examined influenza vaccine effectiveness against nonspecific serious outcomes suffered from selection bias and the lack of laboratory confirmation for influenza infection. The objective of this study was to determine the effectiveness of the 2010-2011 seasonal influenza vaccine against laboratory-confirmed influenza hospitalizations among community-dwelling elderly adults, a serious and highly specific outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS"> We conducted a test-negative study of community-dwelling adults aged >65 years in Ontario, Canada. Respiratory specimens collected between 1 December 2010 and 30 April 2011 from patients admitted to acute care hospitals were tested for influenza using nucleic acid amplification techniques. Influenza vaccination was ascertained from physician billing claims through linkage to health administrative datasets.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS"> Receipt of the 2010-2011 seasonal influenza vaccine was associated with a 42% (95% confidence interval, 29%-53%) reduction in laboratory-confirmed influenza hospitalizations. Vaccine effectiveness estimates were consistent across age groups, by sex, and regardless of outcome severity, timing of testing, and when considering individuals vaccinated <7 or <14 days prior to admission as unvaccinated.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS"> Results of this study will better inform decision making regarding influenza vaccination of elderly adults. Similar analyses are needed annually due to antigenic drift and frequent changes in influenza vaccine composition. The linkage of routinely collected laboratory testing and health administrative data represents an efficient method for estimating influenza vaccine effectiveness that complements prospective studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Jeffrey C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario, Canada. jeff.kwong@utoronto.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campitelli</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Gubbay</LastName><ForeName>Jonathan B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Peci</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Anne-Luise</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Olsha</LastName><ForeName>Romy</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Rosella</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Crowcroft</LastName><ForeName>Natasha S</ForeName><Initials>NS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CIHR XIN 82408</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">elderly adults</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">influenza vaccine</Keyword><Keyword MajorTopicYN="N">vaccine effectiveness</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23788243</ArticleId><ArticleId IdType="pii">cit404</ArticleId><ArticleId IdType="doi">10.1093/cid/cit404</ArticleId><ArticleId IdType="pmc">PMC3749748</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2010 Dec 16;29(2):240-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21044667</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Oct 21;28(45):7267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20832494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Feb 24;29(10):1935-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21219986</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 May 1;203(9):1309-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21378375</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(11):e27622</Citation><ArticleIdList><ArticleId IdType="pubmed">22110695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22032844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jan 5;30(2):195-200</Citation><ArticleIdList><ArticleId IdType="pubmed">22100636</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2012 Mar 26;172(6):484-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22371873</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2012 Jun;54(12):1778-83</Citation><ArticleIdList><ArticleId IdType="pubmed">22423139</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2012 Aug;55(3):332-42</Citation><ArticleIdList><ArticleId IdType="pubmed">22539661</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2012 Oct;55(7):951-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22843783</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2012;12:458</Citation><ArticleIdList><ArticleId IdType="pubmed">22716096</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013;18(5). pii: 20390</Citation><ArticleIdList><ArticleId IdType="pubmed">23399425</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Apr 19;31(17):2165-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23499601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2001 Jan;39(1):196-200</Citation><ArticleIdList><ArticleId IdType="pubmed">11136770</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 May 1;21(16):1780-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12686094</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Clin Pharmacol. 2003 Summer;10(2):67-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12879144</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2004 Mar-Apr;95(2):90-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15074896</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15367555</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Serv Res. 1991 Apr;26(1):53-74</Citation><ArticleIdList><ArticleId IdType="pubmed">1901841</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Dec 7;272(21):1661-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7966893</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2005 Feb 14;165(3):265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15710788</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">16368725</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2006 Aug;59(8):802-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16828673</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Jan 26;25(7):1270-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17079057</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2007 Jun;36(3):623-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17403908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2007 Oct;7(10):658-66</Citation><ArticleIdList><ArticleId IdType="pubmed">17897608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Jan 15;199(2):159-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19086915</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Dec 10;28(1):228-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19796721</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 Feb 15;203(4):500-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21220776</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name><name sortKey="Olsha, Romy" sort="Olsha, Romy" uniqKey="Olsha R" first="Romy" last="Olsha">Romy Olsha</name><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name><name sortKey="Turner, Robert" sort="Turner, Robert" uniqKey="Turner R" first="Robert" last="Turner">Robert Turner</name><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name></noCountry><country name="Canada"><noRegion><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000312 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000312 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23788243
|texte= Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23788243" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |